![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Enrollment ongoing for PSMA-TRACTr (JANX007) in prostate cancer Enrollment ongoing for EGFR-TRACTr (JANX008) in solid tumors Update on JANX007 data and doses selected for expansion cohorts is...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.58 | -6.01679104478 | 42.88 | 43.855 | 39 | 502829 | 41.07631862 | CS |
4 | -5.32 | -11.6615519509 | 45.62 | 56 | 39 | 832310 | 47.21200626 | CS |
12 | 1.95 | 5.08474576271 | 38.35 | 65.6 | 34.6425 | 862193 | 49.24296934 | CS |
26 | 29.56 | 275.232774674 | 10.74 | 65.6 | 7.79 | 751293 | 45.46131781 | CS |
52 | 27.78 | 221.884984026 | 12.52 | 65.6 | 5.65 | 425751 | 40.90812754 | CS |
156 | 20.8 | 106.666666667 | 19.5 | 65.6 | 5.65 | 217061 | 33.36860709 | CS |
260 | 6.3 | 18.5294117647 | 34 | 65.6 | 5.65 | 220347 | 33.11290923 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions